NaturemiRI, LLC has competed pre-clinical trails in mice, rats and dogs validating the role of the PMIS Inhibitor System in tissue and bone regeneration, inhibition of periodontal disease, inhibition of colon cancer and thyroid development.

NaturemiRI Team has obtained over $2.7M in NIH funding, $225K in Economic funding and is currently seeking New Investors.

Human phase I clinical trials are in preparation.

The NaturemiRI team presents many invited talks at International and National meetings each year, please stop by and we would be happy to discuss our system and applications.


The NaturemiRI, LLC team received an NIH SBIR Phase I grant to prepare for human bone regeneration clinical trials.

NaturemiRI, LLC has applied for FDA approval of its PMIS for human clinical trials

The NaturemiRI team has presented at many scientific meetings including Experimental Biology, Gordon Conferences, Keystone Symposia, BMES, IADR and University invited seminars.